Literature DB >> 26070748

MDCT findings in small bowel obstruction: implications of the cause and presence of complications on treatment decisions.

Ryan G O'Malley1, Mahmoud M Al-Hawary2, Ravi K Kaza3, Ashish P Wasnik3, Joel F Platt3, Isaac R Francis3.   

Abstract

Small bowel obstruction (SBO) accounts for a considerable proportion of emergency room visits, inpatient admissions, and surgical interventions in the United States. Multi-detector computed tomography (MDCT) plays a key role in imaging patients presenting with acute symptoms suggestive of SBO, which helps in establishing the diagnosis, elucidating the cause of obstruction, and detecting complications, such as ischemia or frank bowel necrosis and perforation. Recently, management of patients with SBO has shifted toward a more conservative approach with supportive care and nasogastric tube decompression, as the obstruction in many cases can resolve spontaneously without the need for operative intervention. However, management decisions in SBO remain notoriously difficult, relying on a combination of clinical, laboratory, and imaging factors to help stratify patients into conservative or surgical treatment. Imaging is often an important factor assisting in the decision-making process since traditional clinical signs of vascular compromise, such as acidosis, fever, leukocytosis, and tachycardia are often unreliable in predicting the need for operative intervention. Thus, it is critically important for radiologists to identify imaging features that suggest or indicated high likelihood of bowel vascular compromise in order to help optimize management prior to the development of bowel ischemia and eventually necrosis. By excluding signs of potentially ischemic or necrotic bowel on MDCT, patients may be spared unnecessary surgery, thus decreasing postsurgical complications and averting potential increase for the risk of future SBO and repeated surgery. Conversely, if imaging features indicate potential vascular compromise of the bowel wall that may lead to bowel ischemia, urgent surgical intervention may prevent progression to bowel necrosis and subsequent perforation.

Entities:  

Keywords:  Bowel obstruction; Computed tomography; Gastrointestinal; Ischemia

Mesh:

Year:  2015        PMID: 26070748     DOI: 10.1007/s00261-015-0477-x

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  6 in total

1.  Spectrum of MDCT Findings in Bowel Obstruction in a Tertiary Care Rural Hospital in Northern India.

Authors:  Ranjana Gupta; Puneet Mittal; Amit Mittal; Sharad Gupta; Kapish Mittal; Arpit Taneja
Journal:  J Clin Diagn Res       Date:  2016-11-01

Review 2.  Small bowel obstruction and intestinal ischemia: emphasizing the role of MDCT in the management decision process.

Authors:  Mariano Scaglione; Michele Galluzzo; Domiziana Santucci; Margherita Trinci; Laura Messina; Ettore Laccetti; Eliodoro Faiella; Bruno Beomonte Zobel
Journal:  Abdom Radiol (NY)       Date:  2020-10-14

Review 3.  A Systematic Review of the Clinical Presentation, Diagnosis, and Treatment of Small Bowel Obstruction.

Authors:  Srinivas R Rami Reddy; Mitchell S Cappell
Journal:  Curr Gastroenterol Rep       Date:  2017-06

Review 4.  Intestinal transplants: review of normal imaging appearance and complications.

Authors:  Bashir Hakim; Daniel T Myers; Todd R Williams; Shunji Nagai; John Bonnett
Journal:  Br J Radiol       Date:  2018-06-05       Impact factor: 3.039

Review 5.  Bowel obstruction: a narrative review for all physicians.

Authors:  Fausto Catena; Belinda De Simone; Federico Coccolini; Salomone Di Saverio; Massimo Sartelli; Luca Ansaloni
Journal:  World J Emerg Surg       Date:  2019-04-29       Impact factor: 5.469

6.  Optimized protocol of multiple post-processing techniques improves diagnostic accuracy of multidetector computed tomography in assessment of small bowel obstruction compared with conventional axial and coronal reformations.

Authors:  Lian-Qin Kuang; Wei Tang; Ran Li; Cheng Cheng; Shuang-Yue Tang; Yi Wang
Journal:  World J Gastroenterol       Date:  2019-03-07       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.